Hong Kong stocks' innovative drug concept sectors fell collectively, with BeiGene (06160.HK) falling more than 5%, 3SBio (01530.HK) and Sihuan Pharmaceutical (00460.HK) falling more than 4%, Luye Pharma (02186.HK), Innovent Biologics (02096.HK) and China Biologic Products (01177.HK) falling more than 3%.

2025-07-21 09:50:55

BeiGene

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Beijing, the "capital of open source", accelerates the construction of domestic open source big models and achieves another breakthrough
                            2025-07-25

                                    Novo Nordisk (NVO.N): The downward revision of its fiscal year sales forecast is related to declining sales of its weight loss drug Wegovy in the United States.
                            2025-07-29

                                    Toyota Motor Corp. is expected to decide as early as Wednesday evening whether to resume operations at its Japanese factories.
                            2025-07-30

                                    The world's first active safety AI battery cell goes into mass production
                            2025-07-27

                                    CATL's losses widened in the afternoon, with A shares falling more than 4% to below 280 yuan and H shares falling more than 7%.
                            2025-07-30